This conversation between Scott Friedman, Laurent Castera, Louise Campbell and Roger Green covers what the panelists found exciting, important or striking about liver science, VCTE, regulatory approvals using NITs or AI, and other issues at TLM 2023. It starts with Roger sharing his belief that regulators are likely to approve NITs only if a small battery of tests (or ideally, a single test) prove valuable in assessing all agents, or at least all agents, for a stage of disease or segment...

Podden och tillhörande omslagsbild på den här sidan tillhör SurfingNASH.com. Innehållet i podden är skapat av SurfingNASH.com och inte av, eller tillsammans med, Poddtoppen.